Article Type
Article
Changed
Display Headline
Diabetic Ketoacidosis as a Presentation of Hemochromatosis
Case in Point
Author(s)
Vazirani S
Kashefi M

Article PDF
027080023.pdf
Author and Disclosure Information

Sondra Vazirani, MD, MPH and Mehran J. Kashefi, DO

Dr. Vazirani is a hospitalist and Dr. Kashefi is an internist, both at the VA Greater Los Angeles Healthcare System, Los Angeles, California. In addition, Dr. Vazirani is an associate clinical professor of medicine and Dr. Kashefi is a clinical instructor, both at the David Geffen School of Medicine, University of California, Los Angeles.

Issue
Federal Practitioner - 27(8)
Publications
Federal Practitioner
Type 2 Diabetes ICYMI
Topics
Diabetes
Page Number
23
Legacy Keywords
diabetes, diabetic ketoacidosis, hemochromatosis gene, HFE, iron deposit, genetic mutation, diabetes mellitus, anticoagulation therapy, warfarin, homozygous HH, HFE C282Y, heme iron, nonheme iron, multiorgan damagediabetes, diabetic ketoacidosis, hemochromatosis gene, HFE, iron deposit, genetic mutation, diabetes mellitus, anticoagulation therapy, warfarin, homozygous HH, HFE C282Y, heme iron, nonheme iron, multiorgan damage
Sections
Clinical Review
Case Reports
Author(s)
Vazirani S
Kashefi M
Author(s)
Vazirani S
Kashefi M
Author and Disclosure Information

Sondra Vazirani, MD, MPH and Mehran J. Kashefi, DO

Dr. Vazirani is a hospitalist and Dr. Kashefi is an internist, both at the VA Greater Los Angeles Healthcare System, Los Angeles, California. In addition, Dr. Vazirani is an associate clinical professor of medicine and Dr. Kashefi is a clinical instructor, both at the David Geffen School of Medicine, University of California, Los Angeles.

Author and Disclosure Information

Sondra Vazirani, MD, MPH and Mehran J. Kashefi, DO

Dr. Vazirani is a hospitalist and Dr. Kashefi is an internist, both at the VA Greater Los Angeles Healthcare System, Los Angeles, California. In addition, Dr. Vazirani is an associate clinical professor of medicine and Dr. Kashefi is a clinical instructor, both at the David Geffen School of Medicine, University of California, Los Angeles.

Article PDF
027080023.pdf
Article PDF
027080023.pdf
Case in Point
Case in Point

Issue
Federal Practitioner - 27(8)
Issue
Federal Practitioner - 27(8)
Page Number
23
Page Number
23
Publications
Federal Practitioner
Type 2 Diabetes ICYMI
Publications
Federal Practitioner
Type 2 Diabetes ICYMI
Topics
Diabetes
Article Type
Article
Display Headline
Diabetic Ketoacidosis as a Presentation of Hemochromatosis
Display Headline
Diabetic Ketoacidosis as a Presentation of Hemochromatosis
Legacy Keywords
diabetes, diabetic ketoacidosis, hemochromatosis gene, HFE, iron deposit, genetic mutation, diabetes mellitus, anticoagulation therapy, warfarin, homozygous HH, HFE C282Y, heme iron, nonheme iron, multiorgan damagediabetes, diabetic ketoacidosis, hemochromatosis gene, HFE, iron deposit, genetic mutation, diabetes mellitus, anticoagulation therapy, warfarin, homozygous HH, HFE C282Y, heme iron, nonheme iron, multiorgan damage
Legacy Keywords
diabetes, diabetic ketoacidosis, hemochromatosis gene, HFE, iron deposit, genetic mutation, diabetes mellitus, anticoagulation therapy, warfarin, homozygous HH, HFE C282Y, heme iron, nonheme iron, multiorgan damagediabetes, diabetic ketoacidosis, hemochromatosis gene, HFE, iron deposit, genetic mutation, diabetes mellitus, anticoagulation therapy, warfarin, homozygous HH, HFE C282Y, heme iron, nonheme iron, multiorgan damage
Sections
Clinical Review
Case Reports
Article Source

PURLs Copyright

Inside the Article

Article PDF Media